Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
ACTIVE_NOT_RECRUITING
NCT03568890
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
510
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Left Atrial Appendage Closure
Thrombosis
Stroke
TIA
Bleeding
ACTIVE_NOT_RECRUITING
NCT05246514
A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC
72
Enrollment(s)
28
Study location(s)
INTERVENTIONAL (PHASE2)
HER2-mutant Non-Small Cell Lung Cancer
RECRUITING
NCT05048797
A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations
450
Enrollment(s)
163
Study location(s)
INTERVENTIONAL (PHASE3)
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ACTIVE_NOT_RECRUITING
NCT05660135
Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
4,000
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
Hypertension
Dyslipidemias
ACTIVE_NOT_RECRUITING
NCT05411887
Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
2,845
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
Hyperlipidemias
Hypertension
NOT_YET_RECRUITING
NCT07126561
Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers
43
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer Patients With an ECOG Performance Status of 2
RECRUITING
NCT06769490
Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia
44
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1)
Acute Myeloid Leukemia
NOT_YET_RECRUITING
NCT07116239
Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome
60
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (NA)
Nephrotic Syndrome
Hypoalbuminemia
11
12
13
14
15